Impact of EGFR-TKI Treatment on the Tumor Immune Microenvironment in EGFR Mutation-Positive Non-Small Cell Lung Cancer von Isomoto, Kohsuke, Haratani, Koji, Hayashi, Hidetoshi, Shimizu, Shigeki, Tomida, Shuta, Niwa, Takashi, Yokoyama, Toshihide, Fukuda, Yasushi, Chiba, Yasutaka, Kato, Ryoji, Tanizaki, Junko, Tanaka, Kaoru, Takeda, Masayuki, Ogura, Takashi, Ishida, Tadashi, Ito, Akihiko, Nakagawa, Kazuhiko

Volltext

Impact of interstitial lung disease associated with immune checkpoint inhibitors on prognosis in patients with non-small-cell lung cancer von Yamagata, Akira, Yokoyama, Toshihide, Fukuda, Yasushi, Ishida, Tadashi

Volltext

Fatal Immune Checkpoint Inhibitor-related Pancreatitis von Ueno, Masayuki, Tsuji, Yoshihisa, Yokoyama, Toshihide, Koyama, Takashi, Uenishi, Yosuke, Ishida, Etsuji, Mizuno, Motowo

Volltext

TRPA1 regulates gastrointestinal motility through serotonin release from enterochromaffin cells von Nozawa, Katsura, Kawabata-Shoda, Eri, Doihara, Hitoshi, Kojima, Ryosuke, Okada, Hidetsugu, Mochizuki, Shinobu, Sano, Yorikata, Inamura, Kohei, Matsushime, Hitoshi, Koizumi, Tomonobu, Yokoyama, Toshihide, Ito, Hiroyuki

Volltext

Tepotinib‐induced hand‐foot skin reaction von Yamano, Takafumi, Yokoyama, Toshihide, Ishida, Tadashi

Volltext

Alectinib re-challenge in small cell lung cancer transformation after chemotherapy failure in a patient with ALK-positive lung cancer: A case report von Yamagata, Akira, Yokoyama, Toshihide, Fukuda, Yasushi, Ishida, Tadashi

Volltext

Association between metastatic sites and first-line pembrolizumab treatment outcome for advanced non–small cell lung cancer with high PD-L1 expression: a retrospective multicenter... von Kawachi, Hayato, Tamiya, Motohiro, Tamiya, Akihiro, Ishii, Seigo, Hirano, Katsuya, Matsumoto, Hirotaka, Fukuda, Yasushi, Yokoyama, Toshihide, Kominami, Ryota, Fujimoto, Daichi, Hosoya, Kazutaka, Suzuki, Hidekazu, Hirashima, Tomonori, Kanazu, Masaki, Sawa, Nobuhiko, Uchida, Junji, Morita, Mitsunori, Makio, Takeshi, Hara, Satoshi, Kumagai, Toru

Volltext

Clinical outcomes in non-small cell lung cancer patients with an ultra-high expression of programmed death ligand-1 treated using pembrolizumab as a first-line therapy: A retrospec... von Edahiro, Ryuya, Kanazu, Masaki, Kurebe, Hiroyuki, Mori, Masahide, Fujimoto, Daichi, Taniguchi, Yoshihiko, Suzuki, Hidekazu, Hirano, Katsuya, Yokoyama, Toshihide, Morita, Mitsunori, Fukuda, Yasushi, Uchida, Junji, Makio, Takeshi, Tamiya, Motohiro

Volltext

Effects of novel TRPA1 receptor agonist ASP7663 in models of drug-induced constipation and visceral pain von Kojima, Ryosuke, Nozawa, Katsura, Doihara, Hitoshi, Keto, Yoshihiro, Kaku, Hidetaka, Yokoyama, Toshihide, Itou, Hiroyuki

Volltext

Serum albumin level as a potential marker for deciding chemotherapy or best supportive care in elderly, advanced non-small cell lung cancer patients with poor performance status von Ikeda, Satoshi, Yoshioka, Hiroshige, Ikeo, Satoshi, Morita, Mitsunori, Sone, Naoyuki, Niwa, Takashi, Nishiyama, Akihiro, Yokoyama, Toshihide, Sekine, Akimasa, Ogura, Takashi, Ishida, Tadashi

Volltext

Clinical factors associated with shorter durable response, and patterns of acquired resistance to first-line pembrolizumab monotherapy in PD-L1-positive non-small-cell lung cancer... von Hosoya, Kazutaka, Fujimoto, Daichi, Morimoto, Takeshi, Kumagai, Toru, Tamiya, Akihiro, Taniguchi, Yoshihiko, Yokoyama, Toshihide, Ishida, Tadashi, Matsumoto, Hirotaka, Hirano, Katsuya, Kominami, Ryota, Tomii, Keisuke, Suzuki, Hidekazu, Hirashima, Tomonori, Tanaka, Satoshi, Uchida, Junji, Morita, Mitsunori, Kanazu, Masaki, Mori, Masahide, Nagata, Kenji, Fukuda, Ikue, Tamiya, Motohiro

Volltext

A randomized trial of sodium alginate prevention of esophagitis in LA-NSCLC receiving chemoradiotherapy: OLCSG1401 von Ninomiya, Kiichiro, Yokoyama, Toshihide, Hotta, Katsuyuki, Oze, Isao, Katsui, Kuniaki, Hata, Tae, Yoshioka, Hiroshige, Bessho, Akihiro, Hosokawa, Shinobu, Kuyama, Shoichi, Kudo, Kenichiro, Kozuki, Toshiyuki, Harada, Daijiro, Yasugi, Masayuki, Murakami, Toshi, Nakanishi, Masamoto, Takigawa, Nagio, Maeda, Yoshinobu, Kiura, Katsuyuki

Volltext

Randomized, open-label phase II study of brigatinib and carboplatin plus pemetrexed and brigatinib alone for chemotherapy-naive patients with ALK-rearranged non-squamous non-small... von Wakuda, Kazushige, Kenmotsu, Hirotsugu, Sato, Yuki, Nakamura, Atsushi, Akamatsu, Hiroaki, Tachihara, Motoko, Miura, Satoru, Yokoyama, Toshihide, Mori, Keita, Nakagawa, Kazuhiko, Yamamoto, Nobuyuki

Volltext

Overall survival analysis of patients enrolled in a randomized phase III trial comparing gefitinib and erlotinib for previously treated advanced lung adenocarcinoma (WJOG5108LFS) von Katakami, Nobuyuki, Yokoyama, Toshihide, Morita, Satoshi, Okamoto, Tatsuro, Urata, Yoshiko, Hattori, Yoshihiro, Iwamoto, Yasuo, Sato, Yuki, Ikeda, Norihiko, Takahashi, Toshiaki, Daga, Haruko, Oguri, Tetsuya, Fujisaka, Yasuhito, Nishino, Kazumi, Sugawara, Shunichi, Kozuki, Toshiyuki, Oki, Masahide, Yamamoto, Nobuyuki, Nakagawa, Kazuhiko

Volltext

Hypothyroidism as an immune-related adverse event caused by atezolizumab in a patient with muscle spasms: a case report von Kawataki, Masanori, Nakanishi, Yosuke, Yokoyama, Toshihide, Ishida, Tadashi

Volltext

Prediction of patients with a tumor proportion score 50% who do not respond to first-line monotherapy with pembrolizumab von Morita, Mitsunori, Tamiya, Motohiro, Fujimoto, Daichi, Tamiya, Akihiro, Suzuki, Hidekazu, Hirano, Katsuya, Fukuda, Yasushi, Yokoyama, Toshihide, Kominami, Ryota, Kanazu, Masaki, Uchida, Junji, Hara, Satoshi, Yamashita, Shuji, Tomioka, Hiromi

Volltext

Histologic transformation of epidermal growth factor receptor–mutated lung cancer von Fujimoto, Daichi, Akamatsu, Hiroaki, Morimoto, Takeshi, Wakuda, Kazushige, Sato, Yuki, Kawa, Yoshitaka, Yokoyama, Toshihide, Tamiya, Motohiro, Hiraoka, Ryota, Shingu, Naoki, Ikeda, Hideki, Tamiya, Akihiro, Kanazu, Masaki, Miyauchi, Eisaku, Miura, Satoru, Yanai, Masaaki, Yomota, Makiko, Morinaga, Ryotaro, Yokoi, Takashi, Hata, Akito, Suzuki, Hidekazu, Matsumoto, Hirotaka, Sakata, Shinya, Furuya, Naoki, Harutani, Yuhei, Nakachi, Ichiro, Otsuki, Ayumu, Uematsu, Shinya, Hara, Satoshi, Yokoo, Keiki, Sugimoto, Takeya, Yamamoto, Nobuyuki

Volltext

Plasma screening for the T790M mutation of EGFR and phase 2 study of osimertinib efficacy in plasma T790M–positive non–small cell lung cancer: West Japan Oncology Group 8815L/LPS s... von Takahama, Takayuki, Azuma, Koichi, Shimokawa, Mototsugu, Takeda, Masayuki, Ishii, Hidenobu, Kato, Terufumi, Saito, Haruhiro, Daga, Haruko, Tsuboguchi, Yuko, Okamoto, Isamu, Otsubo, Kohei, Akamatsu, Hiroaki, Teraoka, Shunsuke, Takahashi, Toshiaki, Ono, Akira, Ohira, Tatsuo, Yokoyama, Toshihide, Sakai, Kazuko, Yamamoto, Nobuyuki, Nishio, Kazuto, Nakagawa, Kazuhiko

Volltext

Incidence of venous thromboembolism in advanced lung cancer and efficacy and safety of direct oral anticoagulants: a multicenter, prospective, observational study (Rising-VTE/NEJ03... von Tsubata, Yukari, Hotta, Takamasa, Hamai, Kosuke, Furuya, Naoki, Yokoyama, Toshihide, Saito, Ryota, Nakamura, Atsushi, Masuda, Takeshi, Hamaguchi, Megumi, Kuyama, Shoichi, Honda, Ryoichi, Senoo, Tadashi, Nakanishi, Masamoto, Yamasaki, Masahiro, Ishikawa, Nobuhisa, Fujitaka, Kazunori, Kubota, Tetsuya, Ohtsu, Hiroshi, Kobayashi, Kunihiko, Isobe, Takeshi

Volltext

Predicting osimertinib‐treatment outcomes through EGFR mutant‐fraction monitoring in the circulating tumor DNA of EGFR T790M‐positive patients with non‐small cell lung cancer (WJOG... von Sakai, Kazuko, Takahama, Takayuki, Shimokawa, Mototsugu, Azuma, Koichi, Takeda, Masayuki, Kato, Terufumi, Daga, Haruko, Okamoto, Isamu, Akamatsu, Hiroaki, Teraoka, Shunsuke, Ono, Akira, Ohira, Tatsuo, Yokoyama, Toshihide, Yamamoto, Nobuyuki, Nakagawa, Kazuhiko, Nishio, Kazuto

Volltext